|
XPO5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.625300E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.789000E-04 |
| Normal-vs-Stage2 |
1.120030E-02 |
| Normal-vs-Stage3 |
1.713610E-02 |
| Normal-vs-Stage4 |
1.160820E-01 |
| Stage1-vs-Stage2 |
7.286800E-01 |
| Stage1-vs-Stage3 |
9.811800E-01 |
| Stage1-vs-Stage4 |
3.153000E-01 |
| Stage2-vs-Stage3 |
7.561000E-01 |
| Stage2-vs-Stage4 |
2.970800E-01 |
| Stage3-vs-Stage4 |
4.380400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.61769999999351E-05 |
| Normal-vs-AfricanAmerican |
5.181600E-01 |
| Normal-vs-Asian |
3.441000E-01 |
| Caucasian-vs-AfricanAmerican |
3.856600E-01 |
| Caucasian-vs-Asian |
1.857830E-01 |
| AfricanAmerican-vs-Asian |
1.546390E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.828350E-04 |
| Normal-vs-Female |
2.934400E-02 |
| Male-vs-Female |
1.036780E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.283950E-02 |
| Normal-vs-Age(41-60Yrs) |
1.197700E-02 |
| Normal-vs-Age(61-80Yrs) |
8.043800E-04 |
| Normal-vs-Age(81-100Yrs) |
8.991700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.962200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.546600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.491800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.522000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.326180E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.561400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.644000E-02 |
| Normal-vs-Grade 2 |
6.08149999999918E-05 |
| Normal-vs-Grade 3 |
2.321700E-02 |
| Normal-vs-Grade 4 |
1.916760E-01 |
| Grade 1-vs-Grade 2 |
8.174000E-01 |
| Grade 1-vs-Grade 3 |
7.236400E-01 |
| Grade 1-vs-Grade 4 |
5.471200E-01 |
| Grade 2-vs-Grade 3 |
2.705600E-01 |
| Grade 2-vs-Grade 4 |
2.337200E-01 |
| Grade 3-vs-Grade 4 |
7.143400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.304900E-03 |
| Normal-vs-ccB subtype |
7.321900E-02 |
| ccA subtype-vs-ccB subtype |
6.035800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.891600E-02 |
| Normal-vs-N1 |
9.072400E-01 |
| N0-vs-N1 |
5.334800E-01 |
|
|
